Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 21NETWORK 5INDUSTRY 2OTHER_GOV 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Lymphoma, Large B-Cell, Diffuse 8Sarcoma 5Neoplasms 4Lymphoma, Non-Hodgkin 4Immunoproliferative Disorders 3Recurrence 2Osteosarcoma 2Neoplasm Metastasis 2Lymphoproliferative Disorders 2Lymphoma, Follicular 2Lymphoma, B-Cell 2Lymphoma 2Lymphatic Diseases 2Hematologic Diseases 2Sarcoma, Synovial 1Sarcoma, Endometrial Stromal 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neurofibrosarcoma 1Neuroblastoma 1Neoplasms by Histologic Type 1Liposarcoma 1Leiomyosarcoma 1Immune System Diseases 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Fibrosarcoma 1Desmoplastic Small Round Cell Tumor 1Carcinoma, Renal Cell 1Bone Neoplasms 1B-Cell Malignancies 1

Interventions

Pemetrexed 3mifamurtide 2lenvatinib 2dostarlimab 2belinostat 2Ifosfamide 2Granulocyte-Macrophage Colony-Stimulating Factor 2Gemcitabine 2Etoposide 2Drug Therapy 2Cyclophosphamide 2Cisplatin 2vactosertib 1surufatinib 1sintilimab 1robatumumab 1ridaforolimus 1reolysin 1pembrolizumab 1pazopanib 1omburtamab I-131 1niraparib 1isophosphamide mustard 1fludarabine 1endostar protein 1dinutuximab 1copanlisib 1cc-486 1cabozantinib 1anlotinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Osteosarcoma × Ifosfamide × Clear all
NCT04154189 2024-07-22

A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma

Eisai Inc.

Phase 2 Completed
81 enrolled 22 charts
Sarcoma

Recurrence, Osteosarcoma

NCT02432274 2023-07-11

Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma

Eisai Inc.

Phase 1/2 Completed
117 enrolled 32 charts
Sarcoma

Neoplasms, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡